An Intervention to Improve Pneumococcal Vaccination Uptake in High Risk 50-64 Year Olds vs. Expanded Age-Based Recommendations: An Exploratory Cost-Effectiveness Analysis

Human Vaccines and Immunotherapeutics - United States
doi 10.1080/21645515.2018.1564439
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Cost-Effectiveness of Vaccinating Immunocompetent ≥65 Year Olds With the 13-Valent Pneumococcal Conjugate Vaccine in England

PLoS ONE
Multidisciplinary
2016English

Interventions to Improve Vaccination Uptake and Cost Effectiveness of Vaccination Strategies in Newly Arrived Migrants in the EU/EEA: A Systematic Review

International Journal of Environmental Research and Public Health
MutagenesisPublic HealthEnvironmentalHealthToxicologyOccupational HealthPollution
2018English

Cost-Effectiveness of Pneumococcal Vaccination Strategies for the Elderly in Korea

PLoS ONE
Multidisciplinary
2017English

Cost-Effectiveness of Allergic Rhinitis Treatment: An Exploratory Study

SAGE Open Medicine
Medicine
2018English

An Educational Intervention to Improve Inpatient Documentation of High-Risk Diagnoses by Pediatric Residents

Hospital pediatrics
MedicineChild HealthPediatricsPerinatology
2018English

A Hospital-Based Pharmacy Intervention Program for Pneumococcal Vaccination

Archives of Internal Medicine
1998English

Factors Affecting Influenza Vaccination in Adults Aged 50-64 Years With High-Risk Chronic Diseases in South Korea

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2019English

Educational Attainment of 25-64 Year-Olds (2012)

Education at a Glance 2014
2014English

Missing Data in Trial-Based Cost-Effectiveness Analysis: An Incomplete Journey

Health Economics
Health Policy
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy